Thus, we believe that the dual action of PIP by inhibiting DTX metabolism and P-gp activity could lead to enhanced DTX concentration, resulting in enhanced cytotoxicity and overcoming DTX resistance in prostate tumor, which was also suggested by others [44]. This evidence concerns the gene PGP and prostate neoplasm.